Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
Bcl-9L (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
gl O-GlcNAc
ga O-GalNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
Bcl-9L a novel beta-catenin-interacting protein that translocates beta-catenin to the nucleus, enhancing beta-catenin mediated transcription. Can play an important role in colorectal carcinogenesis. Nuclear expression of Bcl-9L is closely associated with the high nuclear grade cancer phenotype and the expression of ErbB2/HER-2 in breast cancers. Note: This description may include information from UniProtKB.
Protein type: Transcription, coactivator/corepressor
Cellular Component: nucleus
Molecular Function: transcription coactivator activity; beta-catenin binding
Biological Process: transcription, DNA-dependent; somatic stem cell maintenance; regulation of cell morphogenesis; positive regulation of transcription from RNA polymerase II promoter; Wnt receptor signaling pathway through beta-catenin; negative regulation of transforming growth factor beta receptor signaling pathway
Reference #:  Q86UU0 (UniProtKB)
Alt. Names/Synonyms: B-cell CLL/lymphoma 9-like; B-cell CLL/lymphoma 9-like protein; B-cell lymphoma 9-like protein; BCL9-2; BCL9-like protein; BCL9L; DLNB11; nuclear co-factor of beta-catenin signalling; Protein BCL9-2
Gene Symbols: BCL9L
Molecular weight: 157,129 Da
Basal Isoelectric point: 8.79  Predict pI for various phosphorylation states
Select Structure to View Below

Bcl-9L

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  RCSB PDB  |  Phospho3D  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 R2 ______MRILANKTR
0 15 S21-p RRREAPGsPPLsPRG
0 11 S25-p APGsPPLsPRGHCPP
0 11 K36-a HCPPAPAkPMHPENk
0 2 K43-a kPMHPENkLTNHGkT
0 11 K49-a NkLTNHGkTGNGGAQ
0 10 K73-a PTCNVGSkGVGAGNH
0 9 S88-p GAKANQIsPsNSsLK
0 1 S90-p KANQIsPsNSsLKNP
0 2 S93-p QIsPsNSsLKNPQAG
0 4 P102 KNPQAGVPPFSSLkG
0 9 K108-a VPPFSSLkGKVKRDR
0 8 K110 PFSSLkGKVKRDRsV
0 8 K112 SSLkGKVKRDRsVsV
0 20 S116-p GKVKRDRsVsVDSGE
0 22 S118-p VKRDRsVsVDSGEQR
0 1 S121 DRsVsVDSGEQREAG
0 4 T129-p GEQREAGtPSLDSEA
0 1 K137-a PSLDSEAkEVAPRSK
0 1 E397-ca QRSLVGSeGLSKEQL
0 1 S424-p IERLLLRsGETEPFL
0 1 T514-p RLGQDSLtPEQVAWR
0 1 R593-m1 VQDPMQLrGGPPFPG
0 1 R602-m1 GPPFPGPrFPGNQIQ
0 1 R602-m2 GPPFPGPrFPGNQIQ
0 1 R610-m1 FPGNQIQrVPGFGGM
0 1 R675 RFMTPRVREELLrHQ
0 2 R680-m2 RVREELLrHQLLEKR
0 1 R680-m1 RVREELLrHQLLEKR
0 7 S750-p GGGRGLLsPPMGQSG
0 5 S813-p LMGPQGLsPEEMARV
0 2 R821-m1 PEEMARVrAQNSSGV
0 12 S915-p RGLGRRPsDLtIsIN
0 1 T918-p GRRPsDLtIsINQMG
0 1 S920-p RPsDLtIsINQMGsP
0 2 S926-p IsINQMGsPGMGHLK
0 4 S934-p PGMGHLKsPtLsQVH
0 1 T936-p MGHLKsPtLsQVHsP
0 3 S938-p HLKsPtLsQVHsPLV
0 5 S942-p PtLsQVHsPLVtsPs
0 3 T946-p QVHsPLVtsPsANLK
0 7 S947-p VHsPLVtsPsANLKs
0 3 S949-p sPLVtsPsANLKsPQ
0 2 S954-p sPsANLKsPQtPsQM
0 1 T957-p ANLKsPQtPsQMVPL
0 1 S959-p LKsPQtPsQMVPLPS
0 6 S975-p NPPGPLKsPQVLGSS
0 1 G980 LKsPQVLGSSLSVRs
0 1 S981 KsPQVLGSSLSVRsP
0 9 S987-p GSSLSVRsPTGsPSR
0 6 S991-p SVRsPTGsPSRLKsP
0 7 S997-p GsPSRLKsPsMAVPs
0 1 S999-p PSRLKsPsMAVPsPG
0 12 S1004-p sPsMAVPsPGWVAsP
0 13 S1010-p PsPGWVAsPKTAMPs
0 10 S1017-p sPKTAMPsPGVSQNK
0 2 S1478-p SHPLRQRsVsLDSQM
0 5 S1480-p PLRQRsVsLDSQMGY
13325 : Phospho-BCL9L (Ser915) Antibody
  mouse

 
R2-m2 ______MrILANKTR
S21-p RRREAPGsPPLsPRG
S25-p APGsPPLsPRGHCPP
K36-a HCPPAPAkPMHPENK
K43 kPMHPENKLTNHGkT
K49-a NKLTNHGkTGNGGAQ
K73-a PTCNLGSkGVGAGSH
S88-p GAKANQIsPsNSsLK
S90-p KANQIsPsNSsLKNP
S93-p QIsPsNSsLKNPQAG
S102-p KNPQAGVsPFSSLkG
K108-a VsPFSSLkGkVkRER
K110-a PFSSLkGkVkRERsV
K112-a SSLkGkVkRERsVsV
S116-p GkVkRERsVsVDsGE
S118-p VkRERsVsVDsGEQR
S121-p ERsVsVDsGEQREAG
T129-p GEQREAGtPSLDSEA
K137 PSLDSEAKEVAPRSK
E394 QRNLVGSEGLSKEQL
S421 IERLLLRSGETEPFL
T511 RLGQDSLTPEQVAWR
R590 VQDPMQLRPGPPFPG
R599 GPPFPGPRFPGNQMQ
R599 GPPFPGPRFPGNQMQ
R607 FPGNQMQRVPGFGGM
R672-m2 RFMTPRVrEELLrHQ
R677-m2 RVrEELLrHQLLEKR
R677 RVrEELLRHQLLEKR
S747-p GGGRGLLsPPMGQSG
S810 MMGPQGLSPEEMARV
R818 PEEMARVRAQNSSGM
S912-p RGLGRRPsDLTISIN
T915 GRRPsDLTISINQMG
S917 RPsDLTISINQMGsP
S923-p ISINQMGsPGMGHLK
S931-p PGMGHLKsPtLsQVH
T933-p MGHLKsPtLsQVHsP
S935-p HLKsPtLsQVHsPLV
S939-p PtLsQVHsPLVtsPs
T943-p QVHsPLVtsPsANLK
S944-p VHsPLVtsPsANLKS
S946-p sPLVtsPsANLKSPQ
S951 sPsANLKSPQTPSQM
T954 ANLKSPQTPSQMVPL
S956 LKSPQTPSQMVPLPS
S972-p NPPGPLKsPQVLssS
S977-p LKsPQVLssSLGVRs
S978-p KsPQVLssSLGVRsP
S984-p ssSLGVRsPTGsPSR
S988-p GVRsPTGsPSRLKsP
S994-p GsPSRLKsPsMAVPs
S996-p PSRLKsPsMAVPsPG
S1001-p sPsMAVPsPGWVAsP
S1007-p PsPGWVAsPKTAMPs
S1014-p sPKTAMPsPGVSQNK
S1473 SHPLRQRSVSLDSQM
S1475 PLRQRSVSLDSQMGY
13325 : Phospho-BCL9L (Ser915) Antibody
  rat

 
R2 ______MRILANKTR
S21-p RRREAPGsPPLsPRG
S25-p APGsPPLsPRGHCPP
K36 HCPPAPAKPMHPENK
K43 KPMHPENKLTNHGKT
K49 NKLTNHGKTGNGGAQ
K73 PTCNLGSKGVGAGSH
S88 GAKANQISPSNSSLK
S90 KANQISPSNSSLKNP
S93 QISPSNSSLKNPQAG
S102 KNPQAGVSPFSSLKG
K108 VSPFSSLKGKVKRER
K110 PFSSLKGKVKRERSV
K112 SSLKGKVKRERSVsV
S116 GKVKRERSVsVDSGE
S118-p VKRERSVsVDSGEQR
S121 ERSVsVDSGEQREAG
T129 GEQREAGTPSLDSEA
K137 PSLDSEAKEVAPRSK
E394 QRNLVGSEGLSKEQL
S421 IERLLLRSGETEPFL
T511 RLGQDSLTPEQVAWR
- under review  
- under review  
- under review  
R556 MGGNQMQRVPGFGGM
R621 RFMTPRVREELLRHQ
R626 RVREELLRHQLLEKR
R626 RVREELLRHQLLEKR
S696 GGGRGLLSPPMGQSG
S759 MMGPQGLSPEEMARV
R767 PEEMARVRAQNSSGM
S861-p RGLGRRPsDLtIsIN
T864-p GRRPsDLtIsINQMG
S866-p RPsDLtIsINQMGSP
S872 IsINQMGSPGMGHLK
S880 PGMGHLKSPTLSQVH
T882 MGHLKSPTLSQVHSP
S884 HLKSPTLSQVHSPLV
S888 PTLSQVHSPLVtsPs
T892-p QVHSPLVtsPsANLK
S893-p VHSPLVtsPsANLKS
S895-p SPLVtsPsANLKSPQ
S900 sPsANLKSPQTPSQM
T903 ANLKSPQTPSQMVPL
S905 LKSPQTPSQMVPLPS
S921 NPPGPLKSPQVLSSS
S926 LKSPQVLSSSLSVRS
S927 KSPQVLSSSLSVRSP
S933 SSSLSVRSPTGSPSR
S937 SVRSPTGSPSRLKSP
S943 GSPSRLKSPSMAVPS
S945 PSRLKSPSMAVPSPG
S950 SPSMAVPSPGWVASP
S956 PSPGWVASPKTAMPS
S963 SPKTAMPSPGVSQNK
S1422 SHPLRQRSVSLDSQM
S1424 PLRQRSVSLDSQMGY
13325 : Phospho-BCL9L (Ser915) Antibody
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.